Loading interface...

IF-2 5 mg Tablet

Manufactured byCipla Ltd.
ContainsOlopatadine
Description
IF-2 5 mg Tablet contains Olopatadine, which is an anti-allergic medicine. It is used to treat various allergic conditions. This medicine works by stopping the release of a chemical substance called histamine. Thus, it helps to relieve allergy symptoms like redness, itching, watery eyes, skin rashes, swelling, sneezing, runny/stuffy nose, etc. IF-2 5 mg Tablet shows side effects such as headache, fatigue, loss of appetite, dry mouth, etc. These side effects usually subside on their own. However, consult your doctor if they bother you for a long time or worsen. Avoid driving vehicles and operating machines while taking this medication, as it can make you feel drowsy. IF-2 5 mg Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur. IF-2 5 mg Tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you. If you are pregnant or are breastfeeding, consult your doctor before taking this medicine.

Side effects

Major & minor side effects for IF-2 5 mg Tablet

  • Loss of appetite
  • Headache
  • Fatigue
  • Dry mouth
  • Drowsiness

Uses of IF-2 5 mg Tablet

What is it prescribed for?

  • Allergic symptoms
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for IF-2 5 mg Tablet to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The time duration for which IF-2 5 mg Tablet remains active in your body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Avoid consuming alcohol during treatment with IF-2 5 mg Tablet as it may increase the risk of side effects.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for IF-2 5 mg Tablet.
  • Can this medicine be taken during pregnancy?
    Due to the lack of safety information, IF-2 5 mg Tablet is not recommended for use during pregnancy unless clearly needed. Consult your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    Due to the lack of safety information, IF-2 5 mg Tablet is not recommended for use while breastfeeding unless clearly needed. Consult your doctor before taking this medicine.

Allergy

Avoid taking IF-2 5 mg Tablet if you are allergic to this medicine. Seek medical attention if you experience any symptoms such as a skin rash, hives (itchy, painful eruptions that sting), swelling (especially of your face, lips, or tongue), breathing difficulty, etc.
Warnings for special population

Pregnancy

Due to the lack of safety information, IF-2 5 mg Tablet is not recommended for use during pregnancy unless clearly needed. Consult your doctor before taking this medicine.

Breast-feeding

Due to the lack of safety information, IF-2 5 mg Tablet is not recommended for use while breastfeeding unless clearly needed. Consult your doctor before taking this medicine.
General warnings

Driving or operating machines

IF-2 5 mg Tablet may cause drowsiness in some cases. Hence, avoid performing activities that require mental alertness such as driving vehicles or operating machines if you feel drowsy.

Other medicines

IF-2 5 mg Tablet may interact with other medicines, which may increase or decrease the effect of this medicine. Hence, inform your doctor about all your current medications, including herbs and supplements, before starting treatment with IF-2 5 mg Tablet.

Missed Dose

Take the missed dose of IF-2 5 mg Tablet as soon as you remember. If it is time for the next scheduled dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Never take more than the prescribed dose. Seek emergency medical treatment in case of an overdose of IF-2 5 mg Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Avoid consuming alcohol during treatment with IF-2 5 mg Tablet as it may increase the risk of side effects.
Interaction with Medicine
Disease interactions

Kidney Disease

IF-2 5 mg Tablet is excreted via the kidney and may get accumulated in your body if your kidneys are not functioning properly. This may increase the risk of severe side effects. Hence, this medicine should be used with caution if you have kidney problems.

Liver Disease

IF-2 5 mg Tablet should be used with caution if you have liver problems as it may worsen your condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take IF-2 5 mg Tablet as advised by your doctor. Do not break, crush, or chew the tablet. Do not take more or less than the prescribed dose or for a longer duration than recommended. Inform your doctor if you notice any undesirable effects that persist or worsen. Keep IF-2 5 mg Tablet away from the reach of children and pets. Avoid using it after the date of expiry. Ensure that the expired or unused medicine is disposed of properly. Avoid sharing your medicine with others even if their symptoms appear to be the same as yours.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
IF-2 5 mg Tablet works by blocking the release of histamine, a substance in the body that causes allergic symptoms.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Antihistamines

Schedule

Schedule H

Pubchem.ncbi.nlm.nih.gov. 2022. Olopatadine. [online] Available at: < [Accessed 28 January 2022].

https://pubchem.ncbi.nlm.nih.gov/compound/Olopatadine>

Ohara-ch.co.jp. 2022. [online] Available at: < [Accessed 28 January 2022].

https://www.ohara-ch.co.jp/appendix/pdf/inc03/olopatadine5T-SIE.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 7 Feb 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.